Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

BBL (TM) LIM Broth, in glass slant tubes and packaged 100 tubes per carton, catalog #296266.

FDA Recall Z-1294-03 · Posted 2003-10-15

Recalling FirmBecton Dickinson & Co.
Recall StatusTerminated
Product CodeJSD
Date Initiated2003-08-11
Date Terminated2003-11-19
Product Quantity860 cartons

Reason for Recall

Broth for growing selective bacteria may fail to inhibit overgrowth of gram negative microorganisms resulting in the inability to isolate Group B Streptococci.

Firm Action

Recalling firm notified distributors and end user by letter 8/11/03 and advised of product failure. Consignees were requested to discontinue distribution and use and discard product for replacment. Consignees were requested to return response form.

Root Cause

Other

Distribution Pattern

Product was sold to 11 distributors and one end user in the US. Product was additionally distributed to firm''s subsidiaries in Canada and Europe.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑